Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 162, Issue 2, 2013, Pages 137-145

  Greenwood, Tiffany A ^a   Joo, Eun Jeong ^b   Shekhtman, Tatyana ^c   Sadovnick, A Dessa ^d   Remick, Ronald A ^e   Keck, Paul E ^f,g   Mcelroy, Susan L ^f,g   Kelsoe, John R ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Eulji General Hospital   (South Korea)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e ST PAUL S HOSPITAL   (Canada)

^f LINDNER CENTER OF HOPE   (United States)

^g UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Attention deficit hyperactivity disorder; DAT1; Wender Utah rating scale

Indexed keywords

DOPAMINE TRANSPORTER;

ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CHILDHOOD DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY ASSESSMENT; GENETIC VARIABILITY; HUMAN; IMPULSIVENESS; INTRON; MAJOR CLINICAL STUDY; MENTAL INSTABILITY; PRIORITY JOURNAL; RATING SCALE; SINGLE NUCLEOTIDE POLYMORPHISM;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CHILD; CHROMOSOMES, HUMAN, PAIR 5; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; INTRONS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84874162008     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32108     Document Type: Article

References (83)

1. Almasy L, Blangero J. 1998. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62(5): 1198-1211.
2. Angrist B. 1994. Clinical variations of amphetamine psychosis. In: Cho AK, Segal DS, editors. Amphetamine and its analogs. San Diego: Academic Press. pp 387-414.
3. Asherson P, Brookes K, Franke B, Chen W, Gill M, Ebstein RP, Buitelaar J, Banaschewski T, Sonuga-Barke E, Eisenberg J, et al. 2007. Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am J Psychiatry 164(4): 674-677.
4. Barr CL, Xu C, Kroft J, Feng Y, Wigg K, Zai G, Tannock R, Schachar R, Malone M, Roberts W, et al. 2001. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol Psychiatry 49(4): 333-339.
5. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2): 263-265.
6. Bidwell LC, Willcutt EG, McQueen MB, DeFries JC, Olson RK, Smith SD, Pennington BF. 2011. A family based association study of DRD4, DAT1, and 5HTT and continuous traits of attention-deficit hyperactivity disorder. Behav Genet 41(1): 165-174.
7. Biederman J, Faraone SV, Keenan K, Tsuang MT. 1991a. Evidence of familial association between attention deficit disorder and major affective disorders. Arch Gen Psychiatry 48(7): 633-642.
8. Biederman J, Newcorn J, Sprich S. 1991b. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148(5): 564-577.
9. Biederman J, Faraone S, Mick E, Wozniak J, Chen L, Ouellette C, Marrs A, Moore P, Garcia J, Mennin D. et al. 1996. Attention-deficit hyperactivity disorder and juvenile mania: An overlooked comorbidity? J Am Acad Child Adolesc Psychiatry 35(8): 997-1008.
10. Biederman J, Russell R, Soriano J, Wozniak J, Faraone SV. 1998. Clinical features of children with both ADHD and mania: Does ascertainment source make a difference? J Affect Disord 51(2): 101-112.
11. Bora E, Yucel M, Pantelis C. 2009. Cognitive endophenotypes of bipolar disorder: A meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 113(1-2): 1-20.
12. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, Anney R, Franke B, Gill M, Ebstein R. et al. 2006a. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: Association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 11(10): 934-953.
13. Brookes KJ, Mill J, Guindalini C, Curran S, Xu X, Knight J, Chen CK, Huang YS, Sethna V, Taylor E, et al. 2006b. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch Gen Psychiatry 63(1): 74-81.
14. Brookes KJ, Xu X, Anney R, Franke B, Zhou K, Chen W, Banaschewski T, Buitelaar J, Ebstein R, Eisenberg J, et al. 2008. Association of ADHD with genetic variants in the 5′-region of the dopamine transporter gene: Evidence for allelic heterogeneity. Am J Med Genet Part B 147B(8): 1519-1523.
15. Brotman MA, Rooney MH, Skup M, Pine DS, Leibenluft E. 2009. Increased intrasubject variability in response time in youths with bipolar disorder and at-risk family members. J Am Acad Child Adolesc Psychiatry 48(6): 628-635.
16. Carlson GA, Weintraub S. 1993. Childhood behavior problems and bipolar disorder-Relationship or coincidence? J Affect Disord 28(3): 143-153.
17. Chen CK, Chen SL, Mill J, Huang YS, Lin SK, Curran S, Purcell S, Sham P, Asherson P. 2003. The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample. Mol Psychiatry 8(4): 393-396.
18. Cook EH, Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL. 1995. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56(4): 993-998.
19. Curran S, Mill J, Tahir E, Kent L, Richards S, Gould A, Huckett L, Sharp J, Batten C, Fernando S, et al. 2001. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry 6(4): 425-428.
20. Daly G, Hawi Z, Fitzgerald M, Gill M. 1999. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 4(2): 192-196.
21. Dick DM, Foroud T, Flury L, Bowman ES, Miller MJ, Rau NL, Moe PR, Samavedy N, El-Mallakh R, Manji H, et al. 2003. Genomewide linkage analyses of bipolar disorder: A new sample of 250 pedigrees from the national institute of mental health genetics initiative. Am J Hum Genet 73(1): 107-114.
22. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25(2): 115-121.
23. Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66(2): 87-98.
24. Faraone SV, Biederman J, Mennin D, Wozniak J, Spencer T. 1997. Attention-deficit hyperactivity disorder with bipolar disorder: A familial subtype? J Am Acad Child Adolesc Psychiatry 36(10): 1378-1387; discussion 1387-1390.
25. Faraone SV, Biederman J, Monuteaux MC. 2001. Attention deficit hyperactivity disorder with bipolar disorder in girls: Further evidence for a familial subtype? J Affect Disord 64(1): 19-26.
26. Faraone SV, Sergeant J, Gillberg C, Biederman J. 2003. The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2(2): 104-113.
27. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11): 1313-1323.
28. Fossati A, Di Ceglie A, Acquarini E, Donati D, Donini M, Novella L, Maffei C. 2001. The retrospective assessment of childhood attention deficit hyperactivity disorder in adults: Reliability and validity of the Italian version of the Wender Utah Rating Scale. Compr Psychiatry 42(4): 326-336.
29. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. 2001. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1(2): 152-156.
30. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. 1999. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283(5400): 397-401.
31. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. 1997. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 2(4): 311-313.
32. Giros B, Caron MG. 1993. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14(2): 43-49.
33. Giros B, el F Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron MG. 1992. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 42(3): 383-390.
34. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379(6566): 606-612.
35. Goldberg JF, Chengappa KN. 2009. Identifying and treating cognitive impairment in bipolar disorder. Bipolar Disord 11(Suppl 2): 123-137.
36. Greenwood TA, Kelsoe JR. 2003. Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics 82(5): 511-520.
37. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Kelsoe JR. 2001. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet 105(2): 145-151.
38. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Shaw SH, Kelsoe JR. 2002. Segmental linkage disequilibrium within the dopamine transporter gene. Mol Psychiatry 7(2): 165-173.
39. Greenwood TA, Schork NJ, Eskin E, Kelsoe JR. 2006. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. Mol Psychiatry 11(2): 125-133.
40. Guindalini C, Howard M, Haddley K, Laranjeira R, Collier D, Ammar N, Craig I, O'Gara C, Bubb VJ, Greenwood T, et al. 2006. A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. Proc Natl Acad Sci USA 103(12): 4552-4557.
41. Hawi Z, Lowe N, Kirley A, Gruenhage F, Nothen M, Greenwood T, Kelsoe J, Fitzgerald M, Gill M. 2003. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 8(3): 299-308.
42. Hawi Z, Kent L, Hill M, Anney RJ, Brookes KJ, Barry E, Franke B, Banaschewski T, Buitelaar J, Ebstein R, et al. 2010. ADHD and DA T1: Further evidence of paternal over-transmission of risk alleles and haplotype. Am J Med Genet Part B 153B(1): 97-102.
43. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR. 2000. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22(2): 133-139.
44. Hill M, Anney RJ, Gill M, Hawi Z. 2010. Functional analysis of intron 8 and 3′ UTR variable number of tandem repeats of SLC6 A3: Differential activity of intron 8 variants. Pharmacogenomics J 10(5): 442-447.
45. Holtmann M, Goth K, Wockel L, Poustka F, Bolte S. 2008. CBCL-pediatric bipolar disorder phenotype: Severe ADHD or bipolar disorder? J Neural Transm 115(2): 155-161.
46. Huang SY, Chen HK, Ma KH, Shy MJ, Chen JH, Lin WC, Lu RB. 2010. Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese. Schizophr Res 116(1): 68-74.
47. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB, Gelernter J. 2000. Prediction of dopamine transporter binding availability by genotype: A preliminary report. Am J Psychiatry 157(10): 1700-1703.
48. Joo EJ, Greenwood TA, Schork N, McKinney RA, Sadovnick AD, Remick RA, Keck PE, McElroy SL, Kelsoe JR. 2009. Suggestive evidence for linkage of ADHD features in bipolar disorder to chromosome 10p14. Am J Med Genet Part B 153B(1): 260-268.
49. Joo EJ, Lee KY, Choi KS, Kim SH, Song JY, Bang YW, Ahn YM, Kim YS. 2012. Childhood attention deficit hyperactivity disorder features in adult mood disorders. Compr Psychiatry 53(3): 217-223.
50. Keikhaee MR, Fadai F, Sargolzaee MR, Javanbakht A, Najmabadi H, Ohadi M. 2005. Association analysis of the dopamine transporter (DAT1)-67A/T polymorphism in bipolar disorder. Am J Med Genet Part B 135B(1): 47-49.
51. Kelsoe JR. 1997. The genetics of bipolar disorder. Psychiatric Ann 27(4): 285-292.
52. Kelsoe JR, Sadovnick AD, Kristbjarnarson H, Bergesch P, Mroczkowski-Parker Z, Drennan M, Rapaport MH, Flodman P, Spence MA, Remick RA. 1996. Possible locus for bipolar disorder near the dopamine transporter on chromosome 5. Am J Med Genet 67(6): 533-540.
53. Kelsoe JR, Spence MA, Loetscher E, Foguet M, Sadovnick AD, Remick RA, Flodman P, Khristich J, Mroczkowski-Parker Z, Brown JL, et al. 2001. A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc Natl Acad Sci USA 98(2): 585-590.
54. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, et al. 2006. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry 163(4): 716-723.
55. Khodayari N, Garshasbi M, Fadai F, Rahimi A, Hafizi L, Ebrahimi A, Najmabadi H, Ohadi M. 2004. Association of the dopamine transporter gene (DAT1) core promoter polymorphism -67T variant with schizophrenia. Am J Med Genet Part B 129B(1): 10-12.
56. Markowitz JS, Straughn AB, Patrick KS. 2003. Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: Focus on methylphenidate formulations. Pharmacotherapy 23(10): 1281-1299.
57. McCann BS, Scheele L, Ward N, Roy-Byrne P. 2000. Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. J Neuropsychiatry Clin Neurosci 12(2): 240-245.
58. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. 2003. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 60(5): 497-502.
59. Michelhaugh SK, Fiskerstrand C, Lovejoy E, Bannon MJ, Quinn JP. 2001. The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem 79(5): 1033-1038.
60. Mill J, Asherson P, Browes C, D'Souza U, Craig I. 2002. Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet (Neuropsychiatric Genetics) 114(8): 975-979.
61. Miller GM, Madras BK. 2002. Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 7(1): 44-55.
62. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T. 1994. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51(11): 849-859; discussion 863-864.
63. Ohadi M, Keikhaee MR, Javanbakht A, Sargolzaee MR, Robabeh M, Najmabadi H. 2007. Gender dimorphism in the DAT-167. T-allele homozygosity and predisposition to bipolar disorder. Brain Res 1144: 142-145.
64. Rubie C, Schmidt F, Knapp M, Sprandel J, Wiegand C, Meyer J, Jungkunz G, Riederer P, Stober G. 2001. The human dopamine transporter gene: The 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample. Neurosci Lett 297(2): 125-128.
65. Ryden E, Thase ME, Straht D, Aberg-Wistedt A, Bejerot S, Landen M. 2009. A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD. Acta Psychiatr Scand 120(3): 239-246.
66. Sachs GS, Lafer B, Stoll AL, Banov M, Thibault AB, Tohen M, Rosenbaum JF. 1994. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 55(9): 391-393.
67. Savitz J, Solms M, Ramesar R. 2005. Neuropsychological dysfunction in bipolar affective disorder: A critical opinion. Bipolar Disord 7(3): 216-235.
68. Silva MA, Cordeiro Q, Louza M, Vallada H. 2009. Association between a SLC6A3 intron 8 VNTR functional polymorphism and ADHD in a Brazilian sample of adult patients. Rev Bras Psiquiatr 31(4): 390-395.
69. Singh MK, DelBello MP, Kowatch RA, Strakowski SM. 2006. Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children. Bipolar Disord 8(6): 710-720.
70. Spitzer RL, Williams JB, Gibbon M, First MB. 1992. The Structured Clinical Interview for DSM-III-R (SCID) I: History, rationale, and description. Arch Gen Psychiatry 49(8): 624-629.
71. Stober G, Sprandel J, Schmidt F, Faul T, Jabs B, Knapp M. 2006. Association study of 5′-UTR polymorphisms of the human dopamine transporter gene with manic depression. Bipolar Disord 8(5 Pt 1): 490-495.
72. Tamam L, Karakus G, Ozpoyraz N. 2008. Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: Prevalence and clinical correlates. Eur Arch Psychiatry Clin Neurosci 258(7): 385-393.
73. Thapar A, Harrington R, Ross K, McGuffin P. 2000. Does the definition of ADHD affect heritability? J Am Acad Child Adolesc Psychiatry 39(12): 1528-1536.
74. Waldman ID, Robinson BF, Feigon SA. 1997. Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: Extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity. Genet Epidemiol 14(6): 699-704.
75. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, Cleveland HH, Sanders ML, Gard JM, Stever C. 1998. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 63(6): 1767-1776.
76. Ward MF, Wender PH, Reimherr FW. 1993. The Wender Utah Rating Scale: An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150(6): 885-890.
77. Waxmonsky J, Pelham WE, Gnagy E, Cummings MR, O'Connor B, Majumdar A, Verley J, Hoffman MT, Massetti GA, Burrows-MacLean L, et al. 2008. The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation. J Child Adolesc Psychopharmacol 18(6): 573-588.
78. Wigginton JE, Abecasis GR. 2005. PEDSTATS: Descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 21(16): 3445-3447.
79. Wilens TE, Biederman J, Wozniak J, Gunawardene S, Wong J, Monuteaux M. 2003. Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults. Biol Psychiatry 54(1): 1-8.
80. Winokur G, Coryell W, Endicott J, Akiskal H. 1993. Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression). Am J Psychiatry 150(8): 1176-1181.
81. Wozniak J, Biederman J, Kiely K, Ablon JS, Faraone SV, Mundy E, Mennin D. 1995. Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 34(7): 867-876.
82. Xu X, Mill J, Sun B, Chen CK, Huang YS, Wu YY, Asherson P. 2009. Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder. BMC Psychiatry 9: 3.
83. Xu M, Xing Q, Li S, Zheng Y, Wu S, Gao R, Yu L, Guo T, Yang Y, Liu J, et al. 2010. Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 34(6): 1026-1032.